Trial intelligence / Profile preview

Colchicine in Acutely Decompensated Heart Failure

NCT04705987Phase 3Completed

Sponsor
Fundación para la Formación e Investigación Sanitaria
Start
Feb 2021
Primary completion
May 2024
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of colchicine in acute decompensated heart failure (ADHF), sponsored by Fundación para la Formación e Investigación Sanitaria. Started Feb 2021; status: completed.

02

Drugs

colchicine
03

Conditions

acute decompensated heart failure (ADHF)

Beyond the preview

Go deeper on NCT04705987.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04705987.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call